CMS vs IMRX · P/E 20, $22.42B cap vs $124.2M cap
CMS Energy Corporation (CMS) versus Immuneering Corp (IMRX) — a side-by-side from cached financials, not a winner call.
CMS Energy Corporation (CMS) is a utilities - regulated electric company listed on US.
Immuneering Corp (IMRX) is a biotechnology company listed on US.
CMS does not have a complete income-statement cache yet.
Latest reported IMRX revenue for 2023-12-31 was $0. Net income was -$53.5M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. IMRX currently screens at market cap $124.2M.
CMS currently screens at market cap $22.42B and trailing P/E 20.1. IMRX currently screens at market cap $124.2M.
Not investment advice. Open the CMS and IMRX stock pages for the full models.
Not investment advice.